Chemoinformaics analysis of 3-Hydroxycinnamic acid
| Molecular Weight | 164.16 | nRot | 2 |
| Heavy Atom Molecular Weight | 156.096 | nRig | 1 |
| Exact Molecular Weight | 164.047 | nRing | 1 |
| Solubility: LogS | -0.032 | nHRing | 0 |
| Solubility: LogP | 0.615 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 22.7703 |
| nHD | 2 | BPOL | 8.89366 |
| QED | 0.444 |
| Synth | 2.735 |
| Natural Product Likeliness | 1.653 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.013 |
| HIA | 0.004 |
| CACO-2 | -4.228 |
| MDCK | 0.000031 |
| BBB | 0.949 |
| PPB | 0.322086 |
| VDSS | 1.077 |
| FU | 0.802908 |
| CYP1A2-inh | 0.346 |
| CYP1A2-sub | 0.707 |
| CYP2c19-inh | 0.041 |
| CYP2c19-sub | 0.735 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.567 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.543 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.182 |
| CL | 8.544 |
| T12 | 0.773 |
| hERG | 0.076 |
| Ames | 0.696 |
| ROA | 0.2 |
| SkinSen | 0.95 |
| Carcinogencity | 0.067 |
| EI | 0.994 |
| Respiratory | 0.962 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.87293 |